Berkeley infectious disease expert studies SARS-CoV-2 live virus in her UC Berkeley lab

Sarah Stanley, an infectious disease expert at UC Berkeley, normally researches tuberculosis in her lab. But when the COVID-19 pandemic shut down all normal research operations on campus, she quickly utilized her own discretionary funds to mobilize her lab and student researchers to study the SARS-CoV-2 live virus.

A partnership with Julia Schaletzky, Executive Director of Berkeley’s Center for Emerging and Neglected Diseases, has allowed Stanley’s lab to test whether pre-existing, FDA approved drugs would have any effect on killing the virus.

Video by Stephen McNally.